Karnataka HC stays action against drug units making Nutraceuticals
AbbVie Healthcare India rejects wrongdoing allegations by the Department of Pharmaceuticals Biocon, Zentiva get EU approval for generic diabetes, weight management drug AbbVie Healthcare under government lens for 'violations' - US FDA restricts imports of some Viatris drugs made at India facility
- Ontario Teachers’ buys into Omega Healthcare
- New list of over the counter drugs soon
- Ontario Teachers' Pension Plan in advanced talks to acquire majority stake in Omega Healthcare
- Zydus Lifesciences gets USFDA nod for generic topical anaesthetic cream
- NPPA ropes in patent office to decide on pleas for price cap exemption
- GIC buys a majority stake in hospital platform Asia Healthcare Holdings
- Quadria Capital to pick up minority stake in drug company Aragen
- Supriya Lifescience opens new API block at Lote Parshuram site in Maharashtra
- 1,394 batches of drugs recalled in 2023-24 for failing quality tests: Minister
- Indoco Remedies gets warning letter from USFDA for Goa plant
ADVERTISEMENT
Biotech
- The Hitchhiker’s Guide to Immortality: Tech entrepreneur Bryan Johnson on 'don’t die' philosophy and mortality
- Glenmark to focus on becoming branded company, says Glenn Saldanha
- Biocon Biologics looks to trim $300 million debt in 1 year
- Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDA
- Zydus gets WHO nod for its typhoid vaccine
Healthcare
- Karnataka HC stays action against drug units making Nutraceuticals
- AbbVie Healthcare India rejects wrongdoing allegations by the Department of Pharmaceuticals
- Biocon, Zentiva get EU approval for generic diabetes, weight management drug
- AbbVie Healthcare under government lens for 'violations'
- Ontario Teachers’ buys into Omega Healthcare
Pharmaceuticals
- US FDA restricts imports of some Viatris drugs made at India facility
- New list of over the counter drugs soon
- Zydus Lifesciences gets USFDA nod for generic topical anaesthetic cream
- NPPA ropes in patent office to decide on pleas for price cap exemption
- Quadria Capital to pick up minority stake in drug company Aragen